Future Connected Drug Delivery Devices Market: Key Dynamics, Size & Share Analysis

The Global Connected Drug Delivery Devices Market size is valued at USD 4.2 Billion in 2024 and is projected to reach USD 11 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 17% during the forecast period, i.e., 2025-30. This growth in the market is due to an increasing number of chronic diseases or NCDs such as diabetes, asthma, cardiovascular, etc. in the world today. According to the WHO, approximately 41 million people are killed every year by chronic diseases that make up about 71% of the overall deaths occurring around the world. Chronic disease cases are on a rise despite the increase in life expectancy rate with proper public healthcare facilities developed worldwide. Intake of substances like alcohol and tobacco contributes to major health hazards. Moreover, having a sedentary lifestyle also contributes to such increasing cases of chronic diseases all over the world. As per the estimates of WHO, at the current trend, by 2050 about 86% of all deaths will be from chronic diseases.

Top Challenges Impacting the Connected Drug Delivery Devices Market Growth

Electronics Integration in Traditional Devices – The traditional drug delivery devices such as traditional injections that come with a small piston are already quite familiar among the patients and are FDA-approved. Therefore, companies do not want to change their mechanical aspects. This leaves the device with very little space for integrating the electronics in it. This results in packing high energy density within the equipment a challenging task. Moreover, this also raises the cost of the devices, particularly in the case of implanted connected devices, which already have limited space availability. The unfolding of such scenarios will restrain the growth in the Global Connected Drug Delivery Devices Market.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Unlock exclusive insights into the Connected Drug Delivery Devices– request your free sample PDF now and explore key trends, growth drivers, and competitive strategies shaping the industry- https://www.marknteladvisors.com/query/request-sample/connected-drug-delivery-devices-market.html

Understanding the Core Segments in the Connected Drug Delivery Devices Market

Connected Drug Delivery Devices Market Size, Share & Industry Trends Analysis- By Device Type (Connected Sensors Devices [Inhalers, Injectors], On-Body Connected Devices, Implanted Connected Devices), By Connectivity (Bluetooth Enabled Devices, Near-Field Communication Enabled Devices, Cellular Enabled Devices, Wide Area Network Enabled Devices), By End User (Hospitals, Clinics, Homecare), By Administration Route (Parenteral, Inhalational, Homecare), By Application (Chronic Diseases [Asthma, Cardiovascular Diseases, Diabetes, Others], Personalized Medicines, Remote Patient Monitoring) and Others

Geographical Analysis of the Connected Drug Delivery Devices Market

  • North America
  • South America
  • Europe
  • The Middle East and Africa
  • Asia-Pacific

North America led the Global Drug Delivery Devices Market with more than 45% market share in 2024.

Who Dominates the Connected Drug Delivery Devices Market Insights on Key Industry Players?

Companies are strengthening their presence in the Connected Drug Delivery Devices market by adopting strategies such as forming strategic alliances, leveraging AI, entering partnerships, pursuing mergers and acquisitions, expanding into new regions, and introducing innovative products and services.

  • Medtronic
  • Insulet
  • Tandem Diabetes Care
  • Bigfoot Biomedical (Abbott)
  • Phillips – Medisize
  • West Pharmaceutical Services, Inc.
  • Roche
  • Becton Dickinson and Company 
  • Cohero Health Inc. (Aptar)
  • Sagentia Innovation
  • CeQur
  • E3D Elcam Drug Delivery Devices
  • BIOCORP
  • Gerresheimer AG
  • Ypsomed AG
  • Nemera
  • Others

Tap into future trends and opportunities shaping the Connected Drug Delivery Devices Market View Full report: - https://www.marknteladvisors.com/research-library/connected-drug-delivery-devices-market.html

Why Choose This MarkNtel Advisors Research Report

  1. Comprehensive Insights – Offers a 360° view of the market, combining qualitative and quantitative analysis for a deep understanding of trends, drivers, challenges, and opportunities.
  2. Reliable Data Sources – Data is gathered through verified primary and secondary sources, ensuring accuracy and credibility.
  3. Actionable Forecasts – Advanced predictive modeling and time-series analysis provide practical insights to guide strategic decisions and business planning.
  4. Expert Analysis – Insights from industry experts help interpret complex market dynamics, delivering clarity beyond the numbers.
  5. Customized & Strategic Reporting – The report includes detailed charts, graphs, and strategic recommendations tailored to support business growth and investment decisions.
  6. Trusted Methodology – Built on rigorous research principles, including precise sampling, data validation, and forecasting techniques, reflecting the trust businesses place in MarkNtel Advisors.

"This report equips decision-makers with actionable intelligence, enabling them to navigate market complexities with confidence and foresight."

Gain exclusive access to our comprehensive insights on the Future of Connected Drug Delivery Devices Market. With tailored licensing options, including Mini Report Pack, Excel Data Pack, Single User, Multiuser, and Enterprise Packs, our research empowers organizations to navigate dynamic market trends effectively.

Select a License That Matches Your Business Requirements with Instant Offer - https://www.marknteladvisors.com/pricing/connected-drug-delivery-devices-market.html   

About us:

MarkNtel Advisors is a distinguished Industry Research Report Firm and Market Research Company offering comprehensive intelligence across the healthcare sector, covering pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our team delivers high-precision Market Research Reports and Business Analysis at global, regional, and country levels to help organizations understand market access strategies, innovation trends, and regulatory frameworks. Using robust data methodologies and validated Market Forecast models, we provide insights that enhance decision-making and operational agility. Our expertise extends to Customized Market Research Reports that measure therapeutic performance, digital transformation, and patient-centric solutions. Through strategic Consulting Services, we empower healthcare companies, investors, and policymakers to quantify Revenue Impact, strengthen competitiveness, and accelerate sustainable growth within the dynamic global healthcare landscape.

Other Reports:

Reach Us:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

We’re always open to sharing insights, exploring ideas. Follow us to stay updated on the latest news and industry trends.